Form D/A — Claris Biotherapeutics, Inc.
0001809726-26-000004 · filed Aug 12, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $121,477,910
- Reported amount sold
- $55,737,646
- Minimum investment
- $0
- Investors
- 14
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Claris Biotherapeutics, Inc.
- CIK
- 1809726
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 475 MAGELLAN AVE
HALF MOON BAY, California 94019 - Phone
- 201-344-7638
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Stephen Brady · Executive OfficerHalf Moon Bay, California Find on LinkedIn ↗
-
Reza Dana · DirectorHalf Moon Bay, California Find on LinkedIn ↗
-
Kenneth Harrison · DirectorHalf Moon Bay, California Find on LinkedIn ↗
-
Marc de Garidel · DirectorHalf Moon Bay, California Find on LinkedIn ↗
-
Meredith Fisher · DirectorHalf Moon Bay, California Find on LinkedIn ↗
-
Henry Rath · Executive OfficerHalf Moon Bay, California Find on LinkedIn ↗
-
Susan Orr · Executive OfficerHalf Moon Bay, California Find on LinkedIn ↗
-
Michael Dybbs · DirectorHalf Moon Bay, California Find on LinkedIn ↗
-
Matt Hobson · DirectorHalf Moon Bay, California Find on LinkedIn ↗
-
Maha Radhakrishnan · DirectorHalf Moon Bay, California Find on LinkedIn ↗
-
Clarke Atwell · Executive OfficerHalf Moon Bay, California Find on LinkedIn ↗
-
Brian Baum · Executive OfficerHalf Moon Bay, California Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗